NPI: 1083908800 · HOUSTON, TX 77082 · End-Stage Renal Disease (ESRD) Treatment Clinic/Center · NPI assigned 06/09/2011
Authorized official WINSTEL, JOHN controls 20+ related entities in our dataset. Read more
| Authorized Official | WINSTEL, JOHN (CHIEF ACCOUNTING OFFICER) |
| NPI Enumeration Date | 06/09/2011 |
Other providers sharing the same authorized official: WINSTEL, JOHN
| Year | Claims | Total Paid |
|---|---|---|
| 2021 | 2,783 | $0.00 |
| 2022 | 1,254 | $237.25 |
| 2023 | 12 | $0.00 |
| Code | Description | Claims | Beneficiaries | Total Paid |
|---|---|---|---|---|
| Q4081 | Injection, epoetin alfa, 100 units (for esrd on dialysis) | 2,481 | 166 | $237.25 |
| G0499 | Hepatitis b screening in non-pregnant, high risk individual includes hepatitis b surface antigen (hbsag), antibodies to hbsag (anti-hbs) and antibodies to hepatitis b core antigen (anti-hbc), and is followed by a neutralizing confirmatory test, when performed, only for an initially reactive hbsag result | 40 | 26 | $0.00 |
| A4657 | Syringe, with or without needle, each | 233 | 228 | $0.00 |
| 83550 | 100 | 90 | $0.00 | |
| 82728 | 112 | 102 | $0.00 | |
| 82306 | Vitamin D; 25 hydroxy, includes fraction(s), if performed | 73 | 70 | $0.00 |
| 83540 | 103 | 90 | $0.00 | |
| 85048 | 246 | 213 | $0.00 | |
| 83970 | 212 | 203 | $0.00 | |
| 85041 | 250 | 216 | $0.00 | |
| 85045 | 199 | 182 | $0.00 |